Section Arrow
Quote
EBS.NYSE
- Emergent BioSolutions Inc.
Quotes are at least 15-min delayed:2026/03/28 17:19 EDT
Regular Hours
Last
 7.93
-0.15 (-1.86%)
Day High 
8.15 
Prev. Close
8.08 
1-M High
9.57 
Volume 
639.80K 
Bid
7.9
Ask
8.02
Day Low
7.9 
Open
8.03 
1-M Low
7.81 
Market Cap 
424.36M 
Currency 美元 
P/E 8.7 
%Yield -- 
10-SMA 8.11 
20-SMA 8.29 
50-SMA 10.08 
52-W High 14.06 
52-W Low 4.02 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
0.93/0.23
Enterprise Value
996.46M
Balance Sheet
Book Value Per Share
10.09
Cash Flow
Cash Flow Yield
0.37
Income Statement
Total Revenue
705.20M
Operating Revenue Per Share
20.44
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
HIMSHims & Hers Health19.38-1.48-7.09%40.92PE
HLNHaleon plc9.8+0.05+0.51%19.79PE
TEVATeva Pharmaceutical Industries Limited28.74-1.04-3.49%24.64PE
ELANElanco Animal Health23.13-1.45-5.90%355.43PE
VTRSViatris13.05-0.32-2.39%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consistingof Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.